CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Financial Officer acquired 1,787 shares (option exercise)
- 4 Open-market buy 10% owner bought 550,000 shares at an average $42.41 ($23,327,560)
- 4 Grant or award Chief Medical Officer acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 40,176 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 73,947 shares (grant or award)
- 4 Open-market buy 10% owner bought 750,000 shares at $19.00 ($14,250,000)
- 4 Exercise or conversion Director acquired 629 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 7,179 shares (option exercise)
- 4 Open-market buy 10% owner bought 282,632 shares at an average $32.24 ($9,111,941)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 17 · 340 filings